233 related articles for article (PubMed ID: 33985854)
1. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
2. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
[TBL] [Abstract][Full Text] [Related]
4. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
6. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
[TBL] [Abstract][Full Text] [Related]
7. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
8. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in adolescent and young adult cancer patients: Pre-treatment findings of a longitudinal study.
Chan A; Cheng I; Wang C; Tan CJ; Toh YL; Ng DQ; Koh YQ; Zhou H; Foo KM; Chan RJ; Ho HK; Chew L; Farid M; Tannock I
Cancer Med; 2023 Feb; 12(4):4821-4831. PubMed ID: 36221816
[TBL] [Abstract][Full Text] [Related]
10. Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels.
Pang L; Li W; Yao S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 May; 12(10):11806-11815. PubMed ID: 36965094
[TBL] [Abstract][Full Text] [Related]
11. Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels.
Nascimento CM; Pereira JR; de Andrade LP; Garuffi M; Talib LL; Forlenza OV; Cancela JM; Cominetti MR; Stella F
Curr Alzheimer Res; 2014; 11(8):799-805. PubMed ID: 25212919
[TBL] [Abstract][Full Text] [Related]
12. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.
Diniz BS; Reynolds CF; Begley A; Dew MA; Anderson SJ; Lotrich F; Erickson KI; Lopez O; Aizenstein H; Sibille EL; Butters MA
J Psychiatr Res; 2014 Feb; 49():96-101. PubMed ID: 24290367
[TBL] [Abstract][Full Text] [Related]
14. Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention.
Pang L; Bi Z; Jing Y; Yin X; Zhang X; Yao S; Zhao J; Cheng H
Am J Cancer Res; 2021; 11(11):5415-5427. PubMed ID: 34873469
[TBL] [Abstract][Full Text] [Related]
15. Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies.
Ng DQ; Chan D; Agrawal P; Zhao W; Xu X; Acharya M; Chan A
Crit Rev Oncol Hematol; 2022 Aug; 176():103748. PubMed ID: 35718064
[TBL] [Abstract][Full Text] [Related]
16. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.
Ng TKS; Coughlan C; Heyn PC; Tagawa A; Carollo JJ; Kua EH; Mahendran R
Aging (Albany NY); 2021 Oct; 13(19):22666-22689. PubMed ID: 34607976
[TBL] [Abstract][Full Text] [Related]
18. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
Stringham NT; Holmes PV; Stringham JM
Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
[TBL] [Abstract][Full Text] [Related]
19. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
